ELIO ROTI,
ROBERTA MINELLI,
ELIANA GARDINI and
LEWIS E. BRAVERMAN
Centro per lo Studio, Prevenzione, Diagnosi e Cura della Tireopatie, Cattedra di Endocrinologia, Universita di Parma Parma, Italy
The Division of Endocrinology and Metabolism, University of Massachusetts Medical School Worcester, Massachusetts 01655
Correspondence: Address requests for reprints to: Lewis E. Braverman, M.D., Division of Endocrinology and Metabolism, University of Massachusetts, 55 Lake Avenue North, Worcester, Massachusetts 01655.
Abstract
I. Introduction: THYROID hormones are frequently prescribed for appropriate and,at times, inappropriate conditions. It has been estimated that1.2% of the total population in Sweden receives synthetic levothyroxine(L-T4) (1), and 18 million prescriptions for thyroid hormonepreparations are filled annually in the United States, correspondingto more than 1% of all medical prescriptions (2). Therefore,it is important to review the various thyroid hormone preparations(Table 1), the therapeutic indications (Table 2), the misuseof thyroid hormone (Table 3), controversial uses of thyroidhormone (Table 4), the thyroid function tests to evaluate thecorrect treatment dose, and the possible side effects of treatment.
Thyroid Hormone Preparations: A. Thyroid extract
Since 1891, when Murray reported the beneficial effects of sheepthyroid extract given im to a patient with myxedema (3), desiccatedthyroid has been used in the treatment of patients with thyroiddisease. Thyroid extract is obtained from animal thyroid glands,primarily cattle, and contains T4 and T3 in variable ratios,depending upon the preparation process and the iodine contentin the diet of the animals from which the thyroids have beenobtained, resulting in variable quantities of T4 and T3 in theextract.
Footnotes
* This work was supported in part by Grants 89.04244.04, 90.01540.CT04,and 91.00316.CT04 from Consiglio Nazionale delle Ricerche (Rome,Italy); Grant "Patologia della Tiroide: Indagine dei FattoriEtiopatogenetici" of Ministero Pubblica Istruzione 40% (Rome,Italy); Grant Ricerca Finalizzata Regione Emilia Romagna 1988–1990;and NIH Grant DK-18919.
Recipients of a fellowship from Associazione Volontaria PromozioneRicerca Tumori (A.VO.PRO.RI.T.), Parma, Italy.
This article has been cited by other articles:
W. Russell, R. F. Harrison, N. Smith, K. Darzy, S. Shalet, A. P. Weetman, and R. J. Ross Free Triiodothyronine Has a Distinct Circadian Rhythm That Is Delayed but Parallels Thyrotropin Levels
J. Clin. Endocrinol. Metab.,
June 1, 2008;
93(6):
2300 - 2306.
[Abstract][Full Text][PDF]
J. P. Walsh, L. C. Ward, V. Burke, C. I. Bhagat, L. Shiels, D. Henley, M. J. Gillett, R. Gilbert, M. Tanner, and B. G. A. Stuckey Small Changes in Thyroxine Dosage Do Not Produce Measurable Changes in Hypothyroid Symptoms, Well-Being, or Quality of Life: Results of a Double-Blind, Randomized Clinical Trial
J. Clin. Endocrinol. Metab.,
July 1, 2006;
91(7):
2624 - 2630.
[Abstract][Full Text][PDF]
F. Santini, A. Pinchera, A. Marsili, G. Ceccarini, M. G. Castagna, R. Valeriano, M. Giannetti, D. Taddei, R. Centoni, G. Scartabelli, et al. Lean Body Mass Is a Major Determinant of Levothyroxine Dosage in the Treatment of Thyroid Diseases
J. Clin. Endocrinol. Metab.,
January 1, 2005;
90(1):
124 - 127.
[Abstract][Full Text][PDF]
D. S. Cooper Combined T4 and T3 Therapy--Back to the Drawing Board
JAMA,
December 10, 2003;
290(22):
3002 - 3004.
[Full Text][PDF]
J. P. Walsh, L. Shiels, E. M. Lim, C. I. Bhagat, L. C. Ward, B. G. A. Stuckey, S. S. Dhaliwal, G. T. Chew, M. C. Bhagat, and A. J. Cussons Combined Thyroxine/Liothyronine Treatment Does Not Improve Well-Being, Quality of Life, or Cognitive Function Compared to Thyroxine Alone: A Randomized Controlled Trial in Patients with Primary Hypothyroidism
J. Clin. Endocrinol. Metab.,
October 1, 2003;
88(10):
4543 - 4550.
[Abstract][Full Text][PDF]
E. Ferretti, L. Persani, M.-L. Jaffrain-Rea, S. Giambona, G. Tamburrano, and P. Beck-Peccoz Evaluation of the Adequacy of Levothyroxine Replacement Therapy in Patients with Central Hypothyroidism
J. Clin. Endocrinol. Metab.,
March 1, 1999;
84(3):
924 - 929.
[Abstract][Full Text]
P. A. Singer, D. S. Cooper, E. G. Levy, P. W. Ladenson, L. E. Braverman, G. Daniels, F. S. Greenspan, I. R. McDougall, and T. F. Nikolai Treatment Guidelines for Patients With Hyperthyroidism and Hypothyroidism
JAMA,
March 8, 1995;
273(10):
808 - 812.
[Abstract][PDF]